Original Article Translational Oncology| Volume 17, ISSUE 4, P519-531, April 01, 2022
Sandeep J. Khandhar MD, FACS – Senior Author on the largest multicenter ENB study to date and the only multinational study to present usage patterns and ENB-aided diagnostic yield with prospective, independently verified 24-month follow-up.
NAVIGATE 24-Month Results: Electromagnetic Navigation Bronchoscopy for Pulmonary Lesions at 37 Centers in Europe and the United States
Erik E. Folch, MD, MSc
Mark R. Bowling, MD, Michael A. Pritchett, DO, MPH, Jennifer J. Wolvers, BSc, Sandeep J. Khandhar, MD for the NAVIGATE Study Investigators#
Published: January 14, 2022
Abstract Introduction
Electromagnetic navigation bronchoscopy (ENB) is a minimally invasive, image-guided approach to access lung lesions for biopsy or localization for treatment. However, no studies have reported prospective 24-month follow-up from a large, multinational, generalizable cohort. This study evaluated ENB safety, diagnostic yield, and usage patterns in an unrestricted, real-world observational design.
